DECCOX 60.6 G/KG PREMIX FOR MEDICATED FEEDING STUFF
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
01-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DECOQUINATE
Available from:
Alpharma BVBA
ATC code:
QP51AX14
Dosage:
60.6
Pharmaceutical form:
Premix for Med.Feedstuffs
Therapeutic group:
Coccidiostats
Therapeutic area:
Bovine
Authorization date:
0000-00-00
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Deccox 60.6 g/kg Premix for Medicated Feeding Stuff
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each kg contains:
Active Substance
Decoquinate
60.6 g
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep, cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and prophylaxis of coccidiosis in lambs and calves during coccidial challenge, by medication of the
feed.
As an aid in the control of coccidiosis in lambs, by medication of ewe feed.
4.3 CONTRAINDICATIONS
None known.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The use of the product will maintain normal growth under conditions of coccidial challenge but does not improve
growth of healthy lambs or calves.
Medication of ewe rations may not prevent coccidiosis occurring in lambs and should only be given in conjunction
with lamb medication.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 22/10/2010_
_CRN 7006091_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
When handling the product, prevent direct contact with the skin, avoid inhaling dust and wash hands after use.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
May be used in pregnant animals.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
Do not mix with or into feeds containing any other anti-coccidial.
IRISH MEDICINES BOARD
________________________________________
Read the complete document
